Identification | Back Directory | [Name]
MTI-31 | [CAS]
1567915-38-1 | [Synonyms]
MTI-31 LXI-15029 Benzamide, N-methyl-3-[2-[(3S)-3-methyl-4-morpholinyl]-4-(3-oxa-8-azabicyclo[3.2.1]oct-8-yl)pyrido[2,3-d]pyrimidin-7-yl]- mTOR kinase inhibitor,tissue factor,mTORC2,mTOR inhibitor,Inhibitor,EGFR mutant cancer,mTOR-TF axis,Mammalian target of Rapamycin,apoptosis,MTI 31,mTOR,inhibit,MTI31,mTORC1,lipid metabolism,tumor microenvironment | [Molecular Formula]
C26H30N6O3 | [MOL File]
1567915-38-1.mol | [Molecular Weight]
474.55 |
Chemical Properties | Back Directory | [density ]
1.275±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 8.33 mg/mL (17.55 mM; ultrasonic and warming and heat to 60°C) | [form ]
Solid | [pka]
14.45±0.46(Predicted) | [color ]
White to yellow |
|
Company Name: |
DC Chemicals
|
Tel: |
021-58447131 13564518121 |
Website: |
http://www.is0513.com/ShowSupplierProductsList927327/0.htm |
|